Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

NCT07052578 · clinicaltrials.gov ↗

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Sponsor

AstraZeneca